News

Nucleai and Merck KGaA Darmstadt, Germany Launch Translational Medicine Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform

Nucleai and Merck KGaA Darmstadt Germany announced a long-term collaboration to leverage Nucleai’s image analysis and biomarker discovery

Contact us

Unsubscribe at any time using the link in our emails.
For details, see our Privacy Policy.

Add Your Heading Text Here